Foley & Lardner LLP announced today that Philippe Riesen has joined the firm’s Intellectual Property Department and Chemical, Biotechnology & Pharmaceutical Practice as a partner in the Tokyo office.
Riesen has been assisting Japanese companies with U.S. patent litigation and counseling for more than 25 years.
He is experienced in a wide range of intellectual property disciplines, including U.S. and multi-district litigation and dispute resolution; America Invents Act (AIA) post-grant proceedings before the Patent Trials and Appeal Board (PTAB) at the U.S. Patent and Trademark Office (USPTO); licensing strategy, drafting and negotiation; commercialization and technology transfer; product and invention due diligence and valuation; patent landscaping and monetization; patent portfolio management; patent prosecution; and regulatory advice and strategies..
“Philippe’s arrival expands our global patent bench in patent litigation and prosecution. Having his boots-on-the ground presence as an experienced litigator and registered U.S. patent attorney based in Tokyo will be an invaluable resource to our Japanese clients,” said Michele Simkin, chair of the firm’s Intellectual Property Department.
Riesen’s technical background is in biochemistry. With his prior experience working in-house at a major pharmaceutical company and litigating numerous Hatch-Waxman cases, he has a particular interest in the pharmaceutical and medical device industry, focusing on litigation, due diligence and life-cycle management. Riesen has also represented companies in intellectual property disputes covering a wide range of technologies ranging from chemicals and bio chemicals, biotechnology, polymers and plastics, to electronics and turbine technology.
“As our clients in Japan seek to enter new markets, they will benefit from Philippe’s knowledge of global intellectual property challenges and opportunities. His experience working with pharmaceutical companies will help expand Foley’s already prominent industry presence in the region,” said Etsuo Doi, managing partner of Foley’s Tokyo office.
Prior to joining Foley, Riesen was a partner at Hogan Lovells and also served as in-house counsel to a major Japanese pharmaceutical company.
Riesen has been assisting Japanese companies with U.S. patent litigation and counseling for more than 25 years.
He is experienced in a wide range of intellectual property disciplines, including U.S. and multi-district litigation and dispute resolution; America Invents Act (AIA) post-grant proceedings before the Patent Trials and Appeal Board (PTAB) at the U.S. Patent and Trademark Office (USPTO); licensing strategy, drafting and negotiation; commercialization and technology transfer; product and invention due diligence and valuation; patent landscaping and monetization; patent portfolio management; patent prosecution; and regulatory advice and strategies..
“Philippe’s arrival expands our global patent bench in patent litigation and prosecution. Having his boots-on-the ground presence as an experienced litigator and registered U.S. patent attorney based in Tokyo will be an invaluable resource to our Japanese clients,” said Michele Simkin, chair of the firm’s Intellectual Property Department.
Riesen’s technical background is in biochemistry. With his prior experience working in-house at a major pharmaceutical company and litigating numerous Hatch-Waxman cases, he has a particular interest in the pharmaceutical and medical device industry, focusing on litigation, due diligence and life-cycle management. Riesen has also represented companies in intellectual property disputes covering a wide range of technologies ranging from chemicals and bio chemicals, biotechnology, polymers and plastics, to electronics and turbine technology.
“As our clients in Japan seek to enter new markets, they will benefit from Philippe’s knowledge of global intellectual property challenges and opportunities. His experience working with pharmaceutical companies will help expand Foley’s already prominent industry presence in the region,” said Etsuo Doi, managing partner of Foley’s Tokyo office.
Prior to joining Foley, Riesen was a partner at Hogan Lovells and also served as in-house counsel to a major Japanese pharmaceutical company.
Related News
06 May 2024
Press Releases
Foley Announces 2024 50-State Telehealth Survey
Foley & Lardner LLP today released the third edition of its 50-State Survey of Telehealth Insurance Laws, which provides a detailed report on each state’s telehealth commercial insurance coverage and payment/reimbursement laws and compares these laws before and after the Public Health Emergency (PHE).
01 May 2024
Press Releases
Foley Continues to Grow Its East Coast Transactions Practice, Adds M&A Partner Jeff Symons in New York
Foley & Lardner LLP announced today that it has strengthened its Transactions Practice with the addition of M&A partner Jeff Symons in New York.
30 April 2024
Press Releases
Foley Ventures Announces Fifth Fund to Invest in Firm Clients
Foley Ventures is pleased to announce Foley Ventures V, its latest venture fund launched in April 2024 to invest in companies and debt and equity fund clients.